Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model

Other recent posts

Article

Human Clinical Trials: A Tool in the Fight Against Infectious Diseases

International Clinical Trials, Autumn 2022, pages 94-97. © Samedan Ltd

View Link

Presentation

RSV Vaccines/Prophylactics: Key learning from the RSV challenge model and efficacy of vaccines

View Link

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.